Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06534255
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-30
Brief Title:
A Clinical Trial to Evaluate the Safety Efficacy and Pharmacokinetics of MegaLT Injection for Treating Refractory Thrombocytopenia Following Radiotherapy Chemotherapy or Transplantation
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Clinical Trial to Evaluate the Safety Efficacy and Pharmacokinetics of MegaLT Injection for Treating Refractory Thrombocytopenia Following Radiotherapy Chemotherapy or Transplantation
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A study to evaluate the safety efficacy and pharmacokinetics of MegaLT in treating refractory thrombocytopenia following radiotherapy chemotherapy or transplantation
Detailed Description:
A single-center open-label dose-escalation study to assess the safety efficacy and pharmacokinetics of MegaLT for treating refractory thrombocytopenia following radiotherapy chemotherapy or transplantation
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None